Regulatory T Cells Control PF4/Heparin Antibody Production in Mice

Area of Science:

• Immunology
• Hematology

Background:

• Heparin-induced thrombocytopenia (HIT) is a severe immune disorder.
• Immune complexes of heparin, platelet factor 4 (PF4), and antibodies drive HIT pathogenesis.
• The role of regulatory T (Treg) cells in controlling PF4/heparin-specific antibody production was previously unknown.

Purpose of the Study:

• To investigate the role of Treg cells in suppressing the production of antibodies against heparin and PF4.
• To determine the involvement of IL-10 in Treg-mediated suppression of PF4/heparin-specific antibody production.

Main Methods:

• Used Foxp3-deficient mice lacking functional Treg cells.
• Transplanted bone marrow cells into Rag1-deficient recipients.
• Adoptively transferred Treg cells into Foxp3-deficient mice.
• Utilized IL-10-deficient mice and CD4 T cell-specific IL-10 deletion models.
• Administered IL-10 to wild-type mice.

Main Results:

• Foxp3-deficient mice spontaneously produced PF4/heparin-specific antibodies.
• Treg cell transfer prevented spontaneous antibody production and inhibited antibody production upon challenge.
• IL-10-deficient mice spontaneously produced PF4/heparin-specific antibodies.
• IL-10 deficiency in CD4 T cells increased antibody production after challenge.
• IL-10 administration suppressed antibody production.

Conclusions:

• Treg cells are critical in suppressing the spontaneous and induced production of PF4/heparin-specific antibodies.
• IL-10 is a key mediator of Treg cell function in preventing antibody responses to heparin/PF4 complexes.
• These findings highlight Treg cells and IL-10 as potential therapeutic targets for HIT.